Neuralink Launches Clinical Trial in Britain to Test Brain Chip

Neuralink Corp., Elon Musk’s brain implant company, is launching a clinical trial in Great Britain to further test its device that allows people to control computers and other electronics with their brains.

The trial will evaluate the safety and functionality of the device in as many as seven patients who have neurological conditions that impair their ability to use electronics, according to an announcement from University College London Hospitals, one of the research sites.